Figure 5: Intravenous iron formulation prescribed by country for the Gulf Cooperation Council- Dialysis Outcomes and Practice Patterns Study hemodialysis population (2012, 2013), among patients with an active i.v. iron prescription any time during the month of enrollment into DOPPS. A wide variation was observed in the use of i.v. iron agents among GCC countries. Iron sucrose was the only formulation used in Oman and Qatar and also the predominant one in UAE, Kuwait, and Saudi Arabia. In Bahrain, its use constituted only 6%, with 35% using dextran, and the remaining being on the other non-sucrose, nongluconate forms of i.v. iron.